|
| Press Releases |
|
 |
|
| Saturday, June 30, 2012 |
|
|
Vivus Shares Set to Gain from Qnexa Despite Vulnerability |
| Vivus (NASDAQ:VVUS) is a company focused on obesity drugs. Its lead candidate, Qnexa, aims to curb obesity in patients with an extended release capsule containing 2 FDA-approved compounds (phentermine and topiramate). more info >> |
|
| Thursday, June 28, 2012 |
|
|
Psivida: Small-Cap Ophthalmology-Based BioTech Positioned for Long-Term Growth |
| pSivida (NASDAQ:PSDV)develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection or insertion. more info >> |
|
| Wednesday, June 27, 2012 |
|
|
Armed with Impressive Partnerships, Can This Emerging Innovator Become 2012's Most Successful Medical Device IPO? |
| Image-guided surgery has revolutionized the accuracy and cost of performing surgery - creating minimally-invasive procedures that allow patients quicker recovery and save clinics, physicians, patients, and health insurers time and money. more info >> |
|
| Friday, June 22, 2012 |
|
|
CEO Sees FDA's Designation as Significant Validation of Medgenics' Novel Technology for Treatment of hepatitis D |
| In near record time, Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics has helped position his relatively new publicly traded company at a much higher level-- one that most other biotech firms usually take far longer to reach. more info >> |
|
| Wednesday, June 20, 2012 |
|
|
Can QRx Pharma Land A Positive FDA Decision? |
| Sydney, Australia based QRx Pharma (PINK:QRXPY) (PINK:QRXPF) (ASX:QRX) is a pharmaceutical company with the vast majority of its prospects tied up in a single drug - MoxDuo. MoxDuo is a combination of two widely used opioids (3:2 ratio of morphine and oxycodone). more info >> |
|
|
Lpath Shares Breaking Out As Investors Seize Discounted Shares |
| Shares of LPath, Inc (NASDAQ:LPTN) are up over 10% in early trading on Tuesday following a report detailing why shares at current prices were a good bet for biotech investors. more info >> |
|
| Friday, June 15, 2012 |
|
|
Orgenesis' Sarah Ferber, Ph.D on Using a Diabetes Patient's Own Liver Cells as a Novel Source of Insulin |
| Diabetes currently afflicts approximately 285 million people worldwide, about 6.4 percent of the global population. The World Health Organization projects that this number is set to rise to 366 million by the year 2030. more info >> |
|
| Friday, March 23, 2012 |
|
|
Healthcare Investors and Capitalists Actively Looking for the Next Generation of Market Movers |
| They may be some of the most talked about market movers today, but companies like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others were once only ideas looking for early investors to back and believe in them. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 8:30 JST
|
|
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
